Korean J Physiol Pharmacol.
1997 Dec;1(6):665-672.
Effect of PAF antagonists on the nitric oxide synthesis in ischemic
cerebral cortex
- Affiliations
-
- 1Department of Pharmacology, College of Medicine, Pusan National University Pusan 602-739, South Korea.
- 2Department of Neurology, College of Medicine, Pusan National University, Pusan 602-739, South Korea.
- 3Department of Neurology, Bong-Seng Hospital, Pusan 601-051, South Korea.
Abstract
-
This study aimed to investigate the mechanism of cerebroprotection of
platelet-activating factor (PAF) antagonists in transient cerebral
ischemia of rat. Right middle cerebral artery (MCA) of Sprague-Dawley
rat was occluded for 2 hours using an intraluminal filament technique.
After 22 hours of reperfusion, morphometrically detectable infarct was
developed in the cortex and striatum identical to the territory of MCA.
The infarct size was significantly reduced by PAF antagonists, BN 52021
and CV-6209, as well as an inducible nitric oxide synthase (iNOS)
inhibitor aminoguanidine (1 mg/kg, i.p., respectively) administered 5
min after MCA occlusion. PAF antagonists significantly inhibited the
enzymatic activities of both myeloperoxidase and iNOS in the cerebral
hemisphere ipsilateral to ischemia, whereas aminoguanidine did not
inhibit myeloperoxidase activity but significantly inhibited the iNOS
activity. These results suggest that PAF antagonists exert a
cerebroprotective effect against ischemic brain damage through
inhibition of leukocyte infiltration and iNOS activity in the
postischemic brain.